Apharga SRL
The score of Apharga shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -50 % Total assets -48 %
Accounts of the company itself (not consolidated).
The full file covers 5 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Apharga's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 08 Jul 2025
- Year ended 31 Dec 2023filed on 23 Jul 2024
- Year ended 31 Dec 2022filed on 11 Jul 2023
- Year ended 31 Dec 2021filed on 12 Jul 2022
Apharga's financial analysis
- Solvency70.0%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Apharga
Apharga's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0762.565.401
- VAT number
- BE0762565401
- Peppol
- Registered · 0208:0762565401 · as of 09 Nov 2026
- Legal form
- SRL
- Incorporated
- 27 Jan 2021
- Registered office
- 4190 Ferrières
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Apharga (SRL) has been based in Ferrières since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 3,449 € and equity of 16,478 €; its revenue is not published. Its solvency stands at 70.0%, above the median of its sector (41.5%).
Companies similar to Apharga
Companies in the same business, of comparable size and area, outside its group.
- STRATEX Consulting Business and other management consultancy activities Sambreville · balance sheet 88,375 €
- El Haibi Consulting Retail sale of pharmaceutical products Jette · balance sheet 19,014 €
- AVICENNE Pharma Services Retail sale of pharmaceutical products Woluwe-Saint-Lambert · balance sheet 42,747 €
- ACP-Pharma Retail sale of pharmaceutical products Affligem · balance sheet 48,017 €
- Lotte Deroover Retail sale of pharmaceutical products Boortmeerbeek · balance sheet 39,701 €
- EL Management Retail sale of pharmaceutical products Waremme · balance sheet 73,614 €
- Medarto Retail sale of medical and orthopaedic goods Nieuwpoort · balance sheet 38,257 €
- Abocor Retail sale of pharmaceutical products Liège · balance sheet 10,389 €
Frequently asked questions about Apharga
What is the revenue of Apharga?
Apharga files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Apharga?
In Belgium, the VAT number is the company number prefixed with BE: BE0762565401 for Apharga, if the company is VAT-registered. Its company number (CBE) is 0762.565.401.
Where is the registered office of Apharga?
According to the CBE register, the registered office of Apharga is in 4190 Ferrières.
What is the equity of Apharga?
At the close of the 2025 financial year, the equity of Apharga amounts to 16,478 €, a solvency of 70.0% of total assets.
Who manages Apharga?
The register lists 1 active mandates at Apharga. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Apharga
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →